Skip to main content
Content Starts Here GSA Federal Advisory Committee Act (FACA) Database Skip to main content

Committee Detail

Note: An Annual Comprehensive Review, as required by §7 of the Federal Advisory Committee Act, is conducted each year on committee data entered for the previous fiscal year (referred to as the reporting year). The data for the reporting year is not considered verified until this review is complete and the data is moved to history for an agency/department. See the Data From Previous Years section at the bottom of this page for the committee’s historical, verified data.

Details on agency responses to committee recommendations can be found under the Performance Measures section for each committee in the fields “Agency Feedback” and “Agency Feedback Comment.”


HHS - 2617 - Lead Exposure and Prevention Advisory Committee - Statutory (Congress Created)
Hide Section - GENERAL INFORMATION

GENERAL INFORMATION

Committee NameLead Exposure and Prevention Advisory CommitteeAgency NameDepartment of Health and Human Services
Fiscal Year2022Committee Number2617
Original Establishment Date1/18/2018Committee StatusChartered
Actual Termination Date Committee URLhttps://www.cdc.gov/nceh/lead/advisory/lepac.htm
New Committee This FYNoPresidential Appointments* 
Terminated This FYNoMax Number of Members*26
Current Charter Date1/17/2022Designated Fed Officer Position Title*Branch Chief
Date Of Renewal Charter1/17/2024Designated Federal Officer PrefixDr.
Projected Termination Date Designated Federal Officer First Name*Paul
Exempt From Renewal*NoDesignated Federal Officer Middle Name
Specific Termination AuthorityDesignated Federal Officer Last Name*Allwood
Establishment Authority*Statutory (Congress Created)Designated Federal Officer SuffixPh.D., M.P.H.
Specific Establishment Authority*Section 2203 of Public Law 114-322, “Water Infrastructure Improvements for the Nation Act”; 42 U.S.C. §300j-27Designated Federal Officer Phone*(770) 488-6774
Effective Date Of Authority*12/16/2016Designated Federal Officer Fax*
Exempt From EO 13875 Discretionary CmteNot ApplicableDesignated Federal Officer Email*iko1@cdc.gov
Committee Type*Continuing
Presidential*No
Committee Function*Scientific Technical Program Advisory Board
Hide Section - RECOMMENDATION/JUSTIFICATIONS

RECOMMENDATION/JUSTIFICATIONS

Agency Recommendation*Continue
Legislation to Terminate RequiredNot Applicable
Legislation StatusNot Applicable
How does cmte accomplish its purpose?*The Committee accomplishes its purpose by reviewing federal programs and services available to lead-exposed individuals and communities; reviewing current research on lead poisoning to identify additional research needs; reviewing and identifying best practices, or the need for best practices, regarding lead screening and the prevention of lead poisoning; identifying effective services for individuals and communities affected by lead exposure; and undertake any other review or activities that the Secretary determines to be appropriate and provide advice to the Secretary. Annually for five years the Committee is required to develop a Report to Congress.
How is membership balanced?*Membership in the Committee shall not exceed 15 members, including both Federal and non-Federal members, with not less than ½ of the members being Federal members. Membership in the Committee shall represent specific fields of expertise including: epidemiology, toxicology, mental health, pediatrics, early childhood and special education, environmental health, and nutrition/dietetics. Membership balance also takes into affect demographic characteristics.
How frequent & relevant are cmte mtgs?*The Committee expects to hold two meetings in FY2023. The Committee will review federal programs and services available to lead-exposed individuals and communities; review current research on lead poisoning to identify additional research needs; review and identify best practices, or the need for best practices, regarding lead screening and the prevention of lead poisoning; identify effective services for individuals and communities affected by lead exposure; and undertake any other review or activities that the Secretary determines to be appropriate and provide advice to the Secretary. As required by Congress, the committee will submit a report of the committee activities, annually for five years. These meetings are necessary to accomplish this requirement.
Why advice can't be obtained elsewhere?*The Water Infrastructure Improvements for the Nation (WIIN) Act [S.612 signed into law on December 16, 2016] authorized HHS to establish an Advisory Committee, in coordination with the Director of the Centers for Disease Control and Prevention and other relevant agencies, as determined by the Secretary consisting of Federal members and non-Federal members which shall include specific fields of expertise (epidemiology, toxicology, mental health, pediatrics, early childhood and special education, environmental health, and nutrition/dietetics). This capability centralized in one Committee does not exist elsewhere in the Department of Health and Human Services.
Why close or partially close meetings?NA
Recommendation RemarksThe committee met twice in FY22. A recommendation that was approved by LEPAC in FY21 was fully implemented in FY22. An annual report for the HHS Secretary was provided for Calendar Year 2021 and a similar report has been prepared for Calendar Year 2022.
Hide Section - PERFORMANCE MEASURES

PERFORMANCE MEASURES

Outcome Improvement To Health Or Safety*YesAction Reorganize Priorities*No
Outcome Trust In GovernmentNoAction Reallocate ResourcesNo
Outcome Major Policy ChangesNoAction Issued New RegulationsNo
Outcome Advance In Scientific ResearchYesAction Proposed LegislationNo
Outcome Effective Grant MakingNoAction Approved Grants Or Other PaymentsNo
Outcome Improved Service DeliveryYesAction OtherNo
Outcome Increased Customer SatisfactionNoAction CommentNot Applicable
Outcome Implement Laws/Reg RequirementsNoGrants Review*No
Outcome OtherYesNumber Of Grants Reviewed 
Outcome CommentRecommendations for policy changesNumber Of Grants Recommended 
Cost Savings*Unable to DetermineDollar Value Of Grants Recommended 
Cost Savings CommentNot ApplicableGrants Review CommentThis is not a grant review committee.
Number Of Recommendations*1Access Contact Designated Fed. Officer*Yes
Number Of Recommendations CommentLEPAC recommended lowering the Blood Lead Reference Value (BLRV). In 2012, CDC adopted the BLRV as a way of identifying the 2.5% of U.S. children ages 1–5 at greatest risk of lead exposure. The BLRV is based on the 97.5th percentile of the blood lead level (BLL) distribution among children 1–5 years old in the U.S. from the two most recent cycles of data from the National Health and Nutrition Examination Survey (NHANES). Thus, based on NHANES data from 2015–2018, CDC accepted the Lead Exposure and Prevention Advisory Committee (LEPAC) recommendation to update the BLRV to 3.5 μg/dL. In October 2021, CDC announced the lower BLRV.Access Agency WebsiteYes
% of Recs Fully Implemented*100.00%Access Committee WebsiteYes
% of Recs Fully Implemented CommentThe recommendation was fully implemented in FY22.Access GSA FACA WebsiteYes
% of Recs Partially Implemented*0.00%Access PublicationsNo
% of Recs Partially Implemented CommentAccess OtherNo
Agency Feedback*YesAccess CommentNot Applicable
Agency Feedback Comment*LEPAC meeting minutes and recommendations are posted and available to the public on CDC's NCEH/ATSDR website.Narrative Description*The Lead Exposure and Prevention Advisory Committee (LEPAC) shall provide advice and guidance to the Secretary of the Department of Health and Human Services and the Director of the Centers for Disease Control and Prevention to support the agency’s mission and its strategic plan by reviewing research and Federal programs and services related to lead poisoning and to identify effective services and best practices for addressing and preventing lead exposure in communities. Annually for five years the Committee is required to develop a Report to Congress.
Hide Section - COSTS

COSTS

Payments to Non-Federal Members*$3,000.00Est Payments to Non-Fed Members Next FY*$7,000.00
Payments to Federal Members*$8,823.00Est. Payments to Fed Members Next FY*$21,719.00
Payments to Federal Staff*$293,660.00Estimated Payments to Federal Staff*$335,768.00
Payments to Consultants*$0.00Est. Payments to Consultants Next FY*$0.00
Travel Reimb. For Non-Federal Members*$0.00Est Travel Reimb Non-Fed Members nextFY*$15,411.00
Travel Reimb. For Federal Members*$0.00Est Travel Reimb For Fed Members*$0.00
Travel Reimb. For Federal Staff*$0.00Est. Travel Reimb to Fed Staff Next FY*$0.00
Travel Reimb. For Consultants*$0.00Est Travel Reimb to Consultants Next FY*$0.00
Other Costs$18,186.00Est. Other Costs Next FY*$30,857.00
Total Costs$323,669.00Est. Total Next FY*$410,755.00
Date Cost Last Modified11/1/2022 12:59 PMEst. Fed Staff Support Next FY*2.10
Federal Staff Support (FTE)*2.00Est Cost Remarks
Cost RemarksTo comply with §2(b)(5) of the FACA, the Federal Management Regulation (FMR Bulletin 2022-F1) requires agencies report all costs of committee activities, including FRN notices for the operation of a committee.  
Hide Section - Interest Areas

Interest Areas

Category
Area
Environment
Environmental Issues
Health
Public Health
Hide Section - MEMBERS,MEETINGS AND ADVISORY REPORTS

MEMBERS,MEETINGS AND ADVISORY REPORTS

To View all the members, meetings and advisory reports for this committee please click here
Hide Section - CHARTERS AND RELATED DOCS

CHARTERS AND RELATED DOCS

No Documents Found
Hide Section - DATA FROM PREVIOUS YEARS

DATA FROM PREVIOUS YEARS

Committee

Data from Previous Years

 
ActionCommittee System IDCommittee NameFiscal Year
 COM-040469Lead Exposure and Prevention Advisory Committee2021
 COM-038744Lead Exposure and Prevention Advisory Committee2020
 COM-036627Lead Exposure and Prevention Advisory Committee2019
 COM-034840Lead Exposure and Prevention Advisory Committee2018